NPFF
gene geneOn this page
Also known as FMRFAL
Summary
NPFF (neuropeptide FF-amide peptide precursor, HGNC:7901) is a protein-coding gene on chromosome 12q13.13, encoding Pro-FMRFamide-related neuropeptide FF (O15130). Morphine modulating peptides.
This gene encodes a member of the FMRFamide related peptide (FARP) family of neuropeptides. The encoded preproprotein is proteolytically processed to generate multiple amidated peptides. These peptides may play a role in the regulation of heart rate and blood pressure and the modulation of morphine-induced antinociception. Patients with hypertension exhibit decreased expression of the encoded protein. Alternative splicing results in multiple transcript variants, at least one of which encodes an isoform that is proteolytically processed.
Source: NCBI Gene 8620 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 1 total
- GTEx eGene: eQTL in 7 tissues, sQTL in 2 (q < 0.05)
- Constraint (gnomAD): pLI 0.00 (LoF-tolerant), LOEUF 1.73 (unconstrained)
- MANE Select transcript:
NM_003717
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:7901 |
| Approved symbol | NPFF |
| Name | neuropeptide FF-amide peptide precursor |
| Location | 12q13.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FMRFAL |
| Ensembl gene | ENSG00000139574 |
| Ensembl biotype | protein_coding |
| OMIM | 604643 |
| Entrez | 8620 |
Gene structure
Transcript identifiers
Ensembl transcripts: 4 — 3 protein_coding, 1 retained_intron
MANE Select: ENST00000267017
Transcript support level (Ensembl TSL; 1 = fully mRNA-supported): TSL 1: 2
ENST00000267017, ENST00000448979, ENST00000940394, ENST00001142754
RefSeq mRNA: 2 — MANE Select: NM_003717
NM_001320296, NM_003717
CCDS: CCDS8862
Canonical transcript exons
ENST00000267017 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000938816 | 53507373 | 53507484 |
| ENSE00002382266 | 53506688 | 53506893 |
| ENSE00003459631 | 53507021 | 53507142 |
Expression profiles
Bgee: expression breadth ubiquitous, 104 present calls, max score 90.44.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.1823 / max 224.5907, expressed in 35 samples.
Highest expression (Bgee): male germ line stem cell (sensu Vertebrata) in testis, primordial germ cell in gonad, colonic epithelium, granulocyte, ganglionic eminence.
Genetic regulation across tissues (GTEx eQTL / sQTL)
NPFF is an eGene in GTEx v10 — its expression is genetically regulated (eQTL) in 7 tissues and its splicing (sQTL) in 2 (q < 0.05). Strongest associations first; slope = normalized effect of the lead variant’s alternative allele.
9 significant tissue × QTL associations:
| Tissue | QTL | q-value | Slope | Lead variant |
|---|---|---|---|---|
| Brain Spinal cord cervical c-1 | eqtl | 1.4e-03 | +1.17 | 12:53836195:C:A |
| Esophagus Gastroesophageal Junction | eqtl | 1.6e-03 | -0.22 | 12:53287171:C:T |
| Prostate | eqtl | 1.3e-02 | -0.16 | 12:53566405:A:G |
| Testis | eqtl | 1.4e-02 | -0.13 | 12:53676278:C:CTG |
| Brain Cerebellum | eqtl | 1.5e-02 | -0.19 | 12:53957592:CG:C |
| Ovary | eqtl | 2.5e-02 | -0.27 | 12:53642530:C:T |
| Brain Hypothalamus | eqtl | 2.7e-02 | +0.51 | 12:54443686:G:A |
| Brain Substantia nigra | sqtl | 4.5e-02 | -3.25 | 12:52555628:A:G |
| Adipose Subcutaneous | sqtl | 4.5e-02 | -0.82 | 12:53150475:T:TA |
FANTOM5 promoters
1 alternative TSS:
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 131248 | 0.1823 | 35 |
Top tissues by expression
showing 100 of 123 tissues by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 90.44 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 84.94 | gold quality |
| colonic epithelium | UBERON:0000397 | 60.93 | gold quality |
| granulocyte | CL:0000094 | 55.36 | gold quality |
| ganglionic eminence | UBERON:0004023 | 54.55 | gold quality |
| cortical plate | UBERON:0005343 | 53.57 | gold quality |
| apex of heart | UBERON:0002098 | 52.85 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 49.76 | gold quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 49.04 | gold quality |
| stromal cell of endometrium | CL:0002255 | 47.74 | gold quality |
| bone marrow cell | CL:0002092 | 46.38 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 46.12 | gold quality |
| duodenum | UBERON:0002114 | 43.43 | gold quality |
| cerebellum | UBERON:0002037 | 43.17 | gold quality |
| cerebellar cortex | UBERON:0002129 | 42.76 | gold quality |
| tonsil | UBERON:0002372 | 42.26 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 42.02 | gold quality |
| ventricular zone | UBERON:0003053 | 41.66 | gold quality |
| prefrontal cortex | UBERON:0000451 | 41.56 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 40.75 | gold quality |
| urinary bladder | UBERON:0001255 | 40.53 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 40.38 | gold quality |
| hypothalamus | UBERON:0001898 | 39.10 | gold quality |
| bone marrow | UBERON:0002371 | 38.89 | silver quality |
| calcaneal tendon | UBERON:0003701 | 38.72 | silver quality |
| blood | UBERON:0000178 | 37.93 | gold quality |
| liver | UBERON:0002107 | 36.50 | gold quality |
| endocervix | UBERON:0000458 | 35.71 | gold quality |
| muscle tissue | UBERON:0002385 | 34.93 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 34.89 | gold quality |
| leukocyte | CL:0000738 | 34.80 | gold quality |
| monocyte | CL:0000576 | 34.19 | gold quality |
| primary visual cortex | UBERON:0002436 | 33.34 | gold quality |
| placenta | UBERON:0001987 | 32.82 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 32.79 | gold quality |
| cortex of kidney | UBERON:0001225 | 32.28 | gold quality |
| frontal cortex | UBERON:0001870 | 32.14 | gold quality |
| lung | UBERON:0002048 | 32.07 | gold quality |
| kidney | UBERON:0002113 | 31.86 | gold quality |
| ascending aorta | UBERON:0001496 | 31.56 | gold quality |
| left uterine tube | UBERON:0001303 | 31.35 | gold quality |
| thoracic aorta | UBERON:0001515 | 31.31 | gold quality |
| gall bladder | UBERON:0002110 | 31.28 | gold quality |
| lymph node | UBERON:0000029 | 31.10 | gold quality |
| vermiform appendix | UBERON:0001154 | 31.08 | gold quality |
| sural nerve | UBERON:0015488 | 30.93 | gold quality |
| ovary | UBERON:0000992 | 30.87 | gold quality |
| islet of Langerhans | UBERON:0000006 | 29.80 | gold quality |
| left ovary | UBERON:0002119 | 29.69 | gold quality |
| right lung | UBERON:0002167 | 29.51 | silver quality |
| uterine cervix | UBERON:0000002 | 29.50 | gold quality |
| brain | UBERON:0000955 | 29.07 | gold quality |
| fallopian tube | UBERON:0003889 | 28.92 | gold quality |
| tibial artery | UBERON:0007610 | 28.92 | gold quality |
| popliteal artery | UBERON:0002250 | 28.83 | gold quality |
| left coronary artery | UBERON:0001626 | 28.62 | gold quality |
| muscle of leg | UBERON:0001383 | 27.96 | gold quality |
| omental fat pad | UBERON:0010414 | 27.71 | gold quality |
| cerebral cortex | UBERON:0000956 | 27.66 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 27.62 | gold quality |
| right ovary | UBERON:0002118 | 27.61 | silver quality |
| multicellular organism | UBERON:0000468 | 26.96 | gold quality |
| pancreas | UBERON:0001264 | 26.78 | gold quality |
| putamen | UBERON:0001874 | 26.54 | gold quality |
| gastrocnemius | UBERON:0001388 | 25.67 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 25.61 | silver quality |
| lower esophagus | UBERON:0013473 | 25.53 | silver quality |
| thoracic mammary gland | UBERON:0005200 | 25.45 | silver quality |
| esophagogastric junction muscularis propria | UBERON:0035841 | 25.37 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 25.31 | gold quality |
| heart | UBERON:0000948 | 25.19 | gold quality |
| right atrium auricular region | UBERON:0006631 | 25.13 | gold quality |
| adipose tissue | UBERON:0001013 | 24.98 | gold quality |
| stomach | UBERON:0000945 | 24.91 | silver quality |
| caudate nucleus | UBERON:0001873 | 24.87 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 24.46 | gold quality |
| descending thoracic aorta | UBERON:0002345 | 24.30 | gold quality |
| endometrium | UBERON:0001295 | 24.28 | gold quality |
| esophagus | UBERON:0001043 | 24.25 | silver quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 24.18 | gold quality |
| superior frontal gyrus | UBERON:0002661 | 24.08 | gold quality |
| adrenal gland | UBERON:0002369 | 24.06 | gold quality |
| colon | UBERON:0001155 | 23.89 | silver quality |
| right lobe of liver | UBERON:0001114 | 23.80 | silver quality |
| intestine | UBERON:0000160 | 23.68 | gold quality |
| body of stomach | UBERON:0001161 | 23.62 | silver quality |
| left adrenal gland cortex | UBERON:0035825 | 23.55 | gold quality |
| skin of abdomen | UBERON:0001416 | 23.36 | gold quality |
| small intestine | UBERON:0002108 | 23.36 | gold quality |
| Ammon’s horn | UBERON:0001954 | 23.18 | gold quality |
| prostate gland | UBERON:0002367 | 22.98 | gold quality |
| adrenal tissue | UBERON:0018303 | 22.80 | gold quality |
| zone of skin | UBERON:0000014 | 22.78 | silver quality |
| thyroid gland | UBERON:0002046 | 22.70 | gold quality |
| heart left ventricle | UBERON:0002084 | 22.68 | silver quality |
| nucleus accumbens | UBERON:0001882 | 22.59 | gold quality |
| tibial nerve | UBERON:0001323 | 22.28 | silver quality |
| ectocervix | UBERON:0012249 | 22.28 | silver quality |
| temporal lobe | UBERON:0001871 | 22.22 | gold quality |
| vagina | UBERON:0000996 | 22.15 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-HCAD-38 | no | 1956.73 |
| E-ANND-3 | no | 0.00 |
HPA expression
RNA tissue specificity: Tissue enriched
46 HPA tissues / cells by nTPM:
| Tissue / cell | Axis | nTPM |
|---|---|---|
| Epididymis | tissue | 1489.7 |
| Cerebellum | tissue | 30.3 |
| Midbrain | tissue | 4.7 |
| Spinal cord | tissue | 4.6 |
| Medulla oblongata | tissue | 4.2 |
| Corpus callosum | tissue | 4.2 |
| Periaqueductal gray | tissue | 4.0 |
| Substantia nigra | tissue | 3.7 |
| Hippocampal formation | tissue | 3.4 |
| Cerebral cortex | tissue | 3.3 |
| Hypothalamus | tissue | 3.3 |
| Insular cortex | tissue | 3.3 |
| Retrosplenial and cingulate cortex | tissue | 3.2 |
| Prefrontal cortex | tissue | 3.1 |
| Pons | tissue | 3.0 |
| Amygdala | tissue | 3.0 |
| Ventral forebrain | tissue | 3.0 |
| Septum | tissue | 3.0 |
| Thalamus | tissue | 2.9 |
| Entorhinal cortex | tissue | 2.9 |
| Motor cortex | tissue | 2.8 |
| Olfactory bulb | tissue | 2.8 |
| Somatosensory cortex | tissue | 2.8 |
| Basal ganglia | tissue | 2.7 |
| Putamen | tissue | 2.7 |
| Temporal cortex | tissue | 2.7 |
| Superior colliculi | tissue | 2.6 |
| Retrosplenial cortex | tissue | 2.4 |
| Occipital cortex | tissue | 2.4 |
| Locus coeruleus | tissue | 0.8 |
| Adrenal gland | tissue | 0.7 |
| Seminal vesicle | tissue | 0.5 |
| Salivary gland | tissue | 0.5 |
| Heart muscle | tissue | 0.3 |
| Retina | tissue | 0.2 |
| Frontal cortex | tissue | 0.2 |
| Gallbladder | tissue | 0.2 |
| Thymus | tissue | 0.2 |
| Caudate putamen | tissue | 0.2 |
| Lymph node | tissue | 0.1 |
| Vagina | tissue | 0.1 |
| Esophagus | tissue | 0.1 |
| Parathyroid gland | tissue | 0.1 |
| Urinary bladder | tissue | 0.1 |
| Bone marrow | tissue | 0.1 |
| Fallopian tube | tissue | 0.1 |
Brain sub-regions (HPA Brain Atlas): detected in 66; highest nTPM — Nucleus tractus solitarii (7.6), Cervical spinal cord, central gray (6.7), Periaquaductal grey, dorsal (6.5), Cervical spinal cord, dorsal horn (5.0), Dorsal spinal cord (4.6).
Regulation
Is transcription factor: no
Upstream regulators (CollecTRI, top): KCNIP3, PDX1, POU1F1, POU2F1
Functional genomics
gnomAD constraint: pLI 6.29e-07, LOEUF 1.73, missense Z -0.0908 — population loss-of-function intolerance (pLI ≥ 0.9 = LoF-intolerant; lower LOEUF = more constrained). gnomAD
Regional missense constraint (gnomAD RMC): no regional variation along ENST00000267017 — one region, missense o/e 1.03.
Literature-anchored findings (GeneRIF, showing 7)
- expression of hNPFF2 receptor mRNA was up-regulated by neuropeptide FF (PMID:16336216)
- neuropeptide FF and micro-opioid receptor association could be a possible molecular basis for anti-opioid activity (PMID:17224450)
- the findings from the early studies on the analgesic and morphine modulating activities suggested a role for NPFF in pain modulation–review (PMID:17854890)
- reduction of NPFF release within the dorsal motor nucleus and ambiguus nucleus could serve as a possible cause of the impairment of cardiac vagal control in hypertensive patients (PMID:21120930)
- Our results…highlight the neuropeptide FF-amide peptide encoding gene (NPFF) as a novel candidate risk gene for both migraine with aura and migraine without aura (PMID:26660531)
- The distribution of Neuropeptide FF and Neuropeptide VF in central and peripheral tissues and their role in energy homeostasis control. (PMID:34534716)
- Renal autocrine neuropeptide FF (NPFF) signaling regulates blood pressure. (PMID:38965251)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | npffl | ENSDARG00000045016 |
| mus_musculus | Npff | ENSMUSG00000023052 |
| rattus_norvegicus | Npff | ENSRNOG00000074090 |
Mouse-model phenotypes
Observed phenotypes of the mouse ortholog (MGI:1891708) from MGI (Alliance of Genome Resources) — knockout/mutant phenotypes, ranked by annotation count. 1 distinct phenotype terms.
| Mouse phenotype (MP) | Records |
|---|---|
| hyperactivity | 1 |
Additional cross-species homologs
Sequence homologs in species beyond Ensembl Compara’s model organisms, by Diamond local protein alignment (% sequence identity; best hit per species). Lower-identity rows are more distant homologs. The matched accessions’ gene symbols aren’t in biobtree yet, so each row shows the UniProt accession.
| Organism | UniProt | Identity | Method |
|---|---|---|---|
| Bos taurus | P15506 | 100.0% | Diamond |
Genomic neighbors (locus context)
Genes flanking this one on the chromosome (NCBI/Entrez gene neighborhood). Positional context only — some neighbors share regulatory elements (bidirectional promoters, antisense/overlapping transcripts), but chromosomal adjacency is not itself a functional relationship (see Interactions for that).
| Symbol | Type | Entrez |
|---|---|---|
| ATF7-AS1 | ncRNA | 100652999 |
| ATF7 | protein-coding | 11016 |
| ATF7-NPFF | protein-coding | 114108587 |
| ATF7-AS2 | ncRNA | 124902937 |
| TARBP2 | protein-coding | 6895 |
| MAP3K12 | protein-coding | 7786 |
| AMHR2 | protein-coding | 269 |
| PCBP2 | protein-coding | 5094 |
| PRR13 | protein-coding | 54458 |
| PCBP2-OT1 | ncRNA | 102157401 |
Protein
Protein identifiers
Pro-FMRFamide-related neuropeptide FF — O15130 (reviewed: O15130)
Alternative names: FMRFamide-related peptides
All UniProt accessions (1): O15130
UniProt curated annotations — full annotation on UniProt →
Function. Morphine modulating peptides. Have wide-ranging physiologic effects, including the modulation of morphine-induced analgesia, elevation of arterial blood pressure, and increased somatostatin secretion from the pancreas. Neuropeptide FF potentiates and sensitizes ASIC1 and ASIC3 channels.
Subcellular location. Secreted.
Similarity. Belongs to the FARP (FMRFamide related peptide) family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| O15130-1 | 1 | yes |
| O15130-2 | 2 |
RefSeq proteins (2): NP_001307225, NP_003708* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR008065 | NPFF | Family |
Pfam: PF15085
UniProt features (11 total): peptide 3, propeptide 2, modified residue 2, signal peptide 1, sequence variant 1, region of interest 1, splice variant 1
Structure
Experimental structures (PDB)
1 structures by resolution:
| PDB | Title | Method | Resolution (Å) |
|---|---|---|---|
| 9JFY | Cryo-EM structure of Neuropeptide FF receptor 2 in complex with hNPSF and Gi | ELECTRON MICROSCOPY | 3.21 |
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-O15130-F1 | 63.92 | 0.04 |
Antibody-complex structures (SAbDab)
1 antibodies co-crystallized with this protein: 9JFY
Human Protein Atlas
Protein class: Predicted secreted proteins
Protein evidence: Evidence at protein level
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2)
| Type | Positions |
|---|---|
| Phenylalanine amide | 76, 110 |
Function
Pathways and Gene Ontology
Reactome pathways
2 curated (TAS) of 8; 0 disease pathways. Curated-first; evidence = TAS (manually curated) vs IEA (electronic inference).
8 pathways:
| ID | Pathway | Evidence |
|---|---|---|
| R-HSA-416476 | G alpha (q) signalling events | curated |
| R-HSA-389397 | Orexin and neuropeptides FF and QRFP bind to their respective receptors | curated |
| R-HSA-373076 | Class A/1 (Rhodopsin-like receptors) | — |
| R-HSA-388396 | GPCR downstream signalling | — |
| R-HSA-500792 | GPCR ligand binding | — |
| R-HSA-375276 | Peptide ligand-binding receptors | — |
| R-HSA-162582 | Signal Transduction | — |
| R-HSA-372790 | Signaling by GPCR | — |
MSigDB gene sets: 176 (showing top):
GOBP_SPINAL_CORD_DEVELOPMENT, MORF_ITGA2, GOBP_MEMBRANE_DEPOLARIZATION, GOBP_REGULATION_OF_BLOOD_PRESSURE, MORF_MSH3, GOBP_CIRCULATORY_SYSTEM_PROCESS, GOBP_INFLAMMATORY_RESPONSE, GOCC_SECRETORY_GRANULE, GOBP_INSULIN_SECRETION, MORF_BRCA1, GOBP_REGULATION_OF_HORMONE_LEVELS, GOBP_NEGATIVE_REGULATION_OF_PEPTIDE_SECRETION, GOBP_RESPONSE_TO_FOOD, GOBP_HORMONE_TRANSPORT, GOBP_REGULATION_OF_MEMBRANE_DEPOLARIZATION
GO Biological Process (15): acute inflammatory response to antigenic stimulus (GO:0002438), regulation of membrane depolarization (GO:0003254), positive regulation of cytosolic calcium ion concentration (GO:0007204), neuropeptide signaling pathway (GO:0007218), chemical synaptic transmission (GO:0007268), response to xenobiotic stimulus (GO:0009410), negative regulation of heart rate (GO:0010459), spinal cord development (GO:0021510), vasopressin secretion (GO:0030103), negative regulation of appetite (GO:0032099), positive regulation of blood pressure (GO:0045777), negative regulation of insulin secretion (GO:0046676), excitatory postsynaptic potential (GO:0060079), maternal process involved in female pregnancy (GO:0060135), somatostatin secretion (GO:0070253)
GO Molecular Function (4): G protein-coupled receptor binding (GO:0001664), signaling receptor binding (GO:0005102), neuropeptide hormone activity (GO:0005184), neuropeptide activity (GO:0160041)
GO Cellular Component (7): extracellular region (GO:0005576), dendrite (GO:0030425), perikaryon (GO:0043204), axon terminus (GO:0043679), postsynapse (GO:0098794), neuronal dense core vesicle (GO:0098992), vesicle (GO:0031982)
Reactome top-level categories
6 top-level categories:
| Category | Pathways |
|---|---|
| Signaling by GPCR | 2 |
| Peptide ligand-binding receptors | 1 |
| GPCR downstream signalling | 1 |
| Signal Transduction | 1 |
| GPCR ligand binding | 1 |
| Class A/1 (Rhodopsin-like receptors) | 1 |
GO top-level categories
41 GO namespaces:
| Category | Terms |
|---|---|
| cellular anatomical structure | 3 |
| peptide hormone secretion | 2 |
| inflammatory response to antigenic stimulus | 1 |
| acute inflammatory response | 1 |
| regulation of membrane potential | 1 |
| regulation of cellular process | 1 |
| membrane depolarization | 1 |
| regulation of biological quality | 1 |
| G protein-coupled receptor signaling pathway | 1 |
| anterograde trans-synaptic signaling | 1 |
| response to chemical | 1 |
| regulation of heart rate | 1 |
| negative regulation of heart contraction | 1 |
| central nervous system development | 1 |
| animal gross anatomical part developmental process | 1 |
| negative regulation of response to food | 1 |
| regulation of appetite | 1 |
| regulation of blood pressure | 1 |
| insulin secretion | 1 |
| negative regulation of protein secretion | 1 |
| regulation of insulin secretion | 1 |
| negative regulation of peptide hormone secretion | 1 |
| regulation of postsynaptic membrane potential | 1 |
| chemical synaptic transmission, postsynaptic | 1 |
| female pregnancy | 1 |
| multicellular organismal reproductive process | 1 |
| signaling receptor binding | 1 |
| protein binding | 1 |
| hormone activity | 1 |
| neuropeptide activity | 1 |
| receptor ligand activity | 1 |
| neuropeptide receptor binding | 1 |
| neuron projection | 1 |
| dendritic tree | 1 |
| neuronal cell body | 1 |
| neuron projection terminus | 1 |
| presynapse | 1 |
| distal axon | 1 |
| synapse | 1 |
| dense core granule | 1 |
| membrane-bounded organelle | 1 |
Experimentally-supported GO annotations
GO terms backed by direct experimental evidence (ECO experimental codes) — 2 of 27 annotations. The rest are phylogenetic / computational / electronic (IEA).
2 experimentally-supported GO terms:
| GO term | NS | Evidence |
|---|---|---|
| neuropeptide signaling pathway | BP | direct assay |
| neuropeptide activity | MF | direct assay |
Protein interactions and networks
STRING
showing 15 of 428 interactions by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| NPFF | NPFFR1 | Q9GZQ6 | 970 |
| NPFF | NPFFR2 | Q9Y5X5 | 965 |
| NPFF | MAS1 | P04201 | 954 |
| NPFF | PRLH | P81277 | 906 |
| NPFF | PRLHR | P49683 | 868 |
| NPFF | MRGPRD | Q8TDS7 | 858 |
| NPFF | MRGPRX2 | Q96LB1 | 852 |
| NPFF | MRGPRX3 | Q96LB0 | 849 |
| NPFF | MRGPRG | Q86SM5 | 827 |
| NPFF | MRGPRX4 | Q96LA9 | 825 |
| NPFF | MRGPRF | Q96AM1 | 824 |
| NPFF | MRGPRX1 | Q96LB2 | 820 |
| NPFF | NPVF | Q9HCQ7 | 813 |
| NPFF | QRFP | P83859 | 757 |
| NPFF | MAS1L | P35410 | 725 |
IntAct
Human interaction partners of NPFF in IntAct, one row per partner (best MIscore; records = supporting IntAct interaction records).
1 partners by confidence:
| Partner | Interaction type | MIscore | Records |
|---|---|---|---|
| ZDHHC17 | physical association | 0.370 | 1 |
BioGRID (2 interactions; top human partners by supporting records): RNF123 (Affinity Capture-MS), ZDHHC17 (Two-hybrid)
SIGNOR signaling
2 signaling interactions:
| A | Effect | B | Mechanism |
|---|---|---|---|
| NPFF | up-regulates | NPFFR1 | binding |
| NPFF | up-regulates | NPFFR2 | binding |
Ligand–receptor pairs (CellPhoneDB) (2)
Curated ligand–receptor partners (cell-cell communication), distinct from the protein–protein interactions above.
2 ligand–receptor pairs:
| Partner | This gene’s role | Signaling class |
|---|---|---|
| NPFFR2 | ligand | Signaling by Neuropeptide precursor |
| NPFFR1 | ligand | Signaling by Neuropeptide precursor |
Disease & clinical
Genetic variants
Variant evidence for NPFF: 1 ClinVar records (0 pathogenic / likely pathogenic); 4 GWAS associations.
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
SpliceAI
Top 10 splice-impact sites by Δscore (adjacent positions with the same effect merged into one range; 27 predictions of 115):
| Position(s) | Effect | Δscore | Sites |
|---|---|---|---|
| 12:53507371–53507372 | donor_loss | 0.9900 | 5 |
| 12:53507371 | donor_loss | 0.9800 | |
| 12:53507019–53507020 | donor_loss | 0.9500 | 4 |
| 12:53507020 | donor_loss | 0.9400 | |
| 12:53507161 | acceptor_gain | 0.9400 | |
| 12:53507150 | acceptor_gain | 0.9200 | |
| 12:53506894–53506895 | acceptor_loss | 0.9000 | 6 |
| 12:53507368 | donor_loss | 0.8700 | |
| 12:53507143–53507144 | acceptor_loss | 0.8600 | 6 |
| 12:53507149 | acceptor_gain | 0.8600 |
AlphaMissense
99 missense substitutions predicted likely pathogenic (of 723 scored), across 24 residues. Top 20 hotspot residues, ranked by the number of likely-pathogenic substitutions (of those reachable by a single-nucleotide change), then by mean score:
| Residue | Likely-pathogenic substitutions | Mean am_pathogenicity | Max am_pathogenicity |
|---|---|---|---|
| F110 | 7 | 0.941 | 0.987 |
| F76 | 7 | 0.912 | 0.981 |
| F71 | 7 | 0.771 | 0.864 |
| G111 | 6 | 0.865 | 0.928 |
| K113 | 6 | 0.819 | 0.886 |
| R75 | 6 | 0.801 | 0.900 |
| P73 | 6 | 0.770 | 0.836 |
| F101 | 5 | 0.866 | 0.889 |
| K112 | 5 | 0.825 | 0.906 |
| R109 | 5 | 0.780 | 0.929 |
| W102 | 5 | 0.756 | 0.846 |
| Q108 | 5 | 0.748 | 0.949 |
| P107 | 5 | 0.722 | 0.806 |
| F69 | 4 | 0.816 | 0.880 |
| Q74 | 4 | 0.760 | 0.921 |
| G77 | 4 | 0.731 | 0.828 |
| S103 | 3 | 0.717 | 0.717 |
| R78 | 3 | 0.702 | 0.727 |
| A105 | 1 | 0.907 | 0.907 |
| A106 | 1 | 0.729 | 0.729 |
HPA cancer prognostics
RNA cancer specificity: Cancer enriched (Testicular Germ Cell Tumor)
Disease associations
OMIM: gene MIM:604643 | disease phenotypes:
GWAS associations
4 associations:
| Study | Trait | p-value |
|---|---|---|
| GCST005956_63 | Waist-to-hip ratio adjusted for BMI | 4e-13 |
| GCST005962_45 | Waist-to-hip ratio adjusted for BMI x sex x age interaction (4df test) | 7e-13 |
| GCST005958_17 | Waist-to-hip ratio adjusted for BMI (age >50) | 1e-8 |
| GCST005957_8 | Waist-to-hip ratio adjusted for BMI (age <50) | 6e-6 |
EFO canonical traits (from GWAS)
3 canonical traits:
| EFO ID | Trait name |
|---|---|
| EFO:0007788 | BMI-adjusted waist-hip ratio |
| EFO:0008007 | age at assessment |
| EFO:0008343 | sex interaction measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (CPIC guideline: no)
CTD chemical–gene interactions
11 total (human), top 11 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| bisphenol A | increases expression | 1 |
| CGP 52608 | affects binding, increases reaction | 1 |
| bisphenol S | affects cotreatment, decreases expression | 1 |
| jinfukang | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dexamethasone | decreases expression, affects cotreatment | 1 |
| Indomethacin | affects cotreatment, decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, decreases expression | 1 |
| Particulate Matter | decreases expression | 1 |
Clinical trials (associated diseases)
Via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.